125 related articles for article (PubMed ID: 7612183)
1. Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI.
Molhuizen HO; Schalkwijk J
Biol Chem Hoppe Seyler; 1995 Jan; 376(1):1-7. PubMed ID: 7612183
[TBL] [Abstract][Full Text] [Related]
2. Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.
Alkemade HA; de Jongh GJ; Arnold WP; van de Kerkhof PC; Schalkwijk J
J Invest Dermatol; 1995 Feb; 104(2):189-93. PubMed ID: 7829874
[TBL] [Abstract][Full Text] [Related]
3. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.
Molhuizen HO; Alkemade HA; Zeeuwen PL; de Jongh GJ; Wieringa B; Schalkwijk J
J Biol Chem; 1993 Jun; 268(16):12028-32. PubMed ID: 7685029
[TBL] [Abstract][Full Text] [Related]
4. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.
Alkemade JA; Molhuizen HO; Ponec M; Kempenaar JA; Zeeuwen PL; de Jongh GJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC; Schalkwijk J
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2335-42. PubMed ID: 7983189
[TBL] [Abstract][Full Text] [Related]
5. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.
Schalkwijk J; de Roo C; de Jongh GJ
Biochim Biophys Acta; 1991 Feb; 1096(2):148-54. PubMed ID: 2001428
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.
Schalkwijk J; van Vlijmen IM; Alkemade JA; de Jongh GJ
J Invest Dermatol; 1993 Apr; 100(4):390-3. PubMed ID: 8454901
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of SKALP/Elafin in human epidermal tumors.
Alkemade HA; Molhuizen HO; van Vlijmen-Willems IM; van Haelst UJ; Schalkwijk J
Am J Pathol; 1993 Dec; 143(6):1679-87. PubMed ID: 8256855
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
Alkemade HA; van Vlijmen-Willems IM; van Haelst UJ; van de Kerkhof PC; Schalkwijk J
J Pathol; 1994 Oct; 174(2):121-9. PubMed ID: 7965407
[TBL] [Abstract][Full Text] [Related]
9. Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13.
Molhuizen HO; Zeeuwen PL; Olde Weghuis D; Geurts van Kessel A; Schalkwijk J
Cytogenet Cell Genet; 1994; 66(2):129-31. PubMed ID: 8287685
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis.
Nonomura K; Yamanishi K; Yasuno H; Nara K; Hirose S
J Invest Dermatol; 1994 Jul; 103(1):88-91. PubMed ID: 8027586
[TBL] [Abstract][Full Text] [Related]
11. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?
Kuijpers AL; Zeeuwen PL; de Jongh GJ; van de Kerkhof PC; Alkemade HA; Schalkwijk J
Arch Dermatol Res; 1996 Oct; 288(11):641-7. PubMed ID: 8931865
[TBL] [Abstract][Full Text] [Related]
12. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity.
Sallenave JM; Marsden MD; Ryle AP
Biol Chem Hoppe Seyler; 1992 Jan; 373(1):27-33. PubMed ID: 1536690
[TBL] [Abstract][Full Text] [Related]
13. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
14. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin".
Nara K; Ito S; Ito T; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S
J Biochem; 1994 Mar; 115(3):441-8. PubMed ID: 7914520
[TBL] [Abstract][Full Text] [Related]
15. Expression of SKALP/elafin during wound healing in human skin.
van Bergen BH; Andriessen MP; Spruijt KI; van de Kerkhof PC; Schalkwijk J
Arch Dermatol Res; 1996 Jul; 288(8):458-62. PubMed ID: 8844125
[TBL] [Abstract][Full Text] [Related]
16. Elafin is a potent inhibitor of proteinase 3.
Wiedow O; Lüademann J; Utecht B
Biochem Biophys Res Commun; 1991 Jan; 174(1):6-10. PubMed ID: 1989620
[TBL] [Abstract][Full Text] [Related]
17. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry.
Suzuki Y; Furukawa M; Abe J; Kashiwagi M; Hirose S
Histochem Cell Biol; 2000 Jul; 114(1):15-20. PubMed ID: 10959818
[TBL] [Abstract][Full Text] [Related]
18. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.
Pfundt R; van Ruissen F; van Vlijmen-Willems IM; Alkemade HA; Zeeuwen PL; Jap PH; Dijkman H; Fransen J; Croes H; van Erp PE; Schalkwijk J
J Clin Invest; 1996 Sep; 98(6):1389-99. PubMed ID: 8823304
[TBL] [Abstract][Full Text] [Related]
19. Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis.
Kuijpers AL; Alkemade HA; Schalkwijk J; van de Kerkhof PC
Acta Derm Venereol; 1995 Mar; 75(2):110-3. PubMed ID: 7604637
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
Alkemade H; van de Kerkhof P; Schalkwijk J
J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
